Last reviewed · How we verify

NCT05253586: VOLARE

Versius or Laparoscopic Abdominal Hernia REpair

Withdrawn Last updated 12 March 2025
What this trial tests

trial testing Laparoscopic in Abdominal Hernia. Withdrawn.

Timeline
31 March 2024
Primary endpoint
31 March 2024
31 March 2024

Quick facts

Lead sponsorJoanne Turner
StatusWithdrawn
Study typeOBSERVATIONAL
Start date31 March 2024
Primary completion31 March 2024
Estimated completion31 March 2024

Drugs / interventions tested

Conditions studied

Sponsor

Joanne Turner

Who can join

Adults 18 to 100, any sex, with Abdominal Hernia or Abdominal Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial will compare laparoscopic and robotic-assisted abdominal hernia repairs, using the Versius® system. We will initially aim to recruit 60 patients (20 patients in the laparoscopic arm and 40 in the robotic arm) in order to assess the ergonomic impact of each modality on the operating surgeon. This aims to provide in vivo information on whether robotic surgery provides any advantages to the operating surgeon. This trial will also be used to assess the feasibility of recruitment to a future larger study, and any data collected will be used as pilot data.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Laparoscopic

Trials testing the same drug.

Other recruiting trials for Abdominal Hernia

Currently open trials in the same condition.

Other Joanne Turner trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05253586.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing